ALNY
Alnylam Pharmaceuticals, Inc.
$400.19
-2.00%
-8.16
Notify me if price changes either direction
Buy ALNY stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
53.9B
Enterprise value
52.9B
Trailing PE
1429.393
Forward PE
37.722385
PEG Ratio
-4.4732802517986
Enterprise to EBITDA
164.863
Enterprise to revenue
16.487
Price to book MRQ
225.4817
Price to sales TTM
16.471888
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
3.2B
EBITDA
321.0M
Diluted EPS TTM
0.28
Total Cash (MRQ)
2.7B
Current ratio (MRQ)
2.541
Operating Cash Flow (TTM)
265.9M
ALNY trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
December 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
